Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Trial details
- Registry ID
- NCT06126380
- Drugs studied
- AT-1501, Tacrolimus
TrialRedline tracks 3 clinical trials sponsored by Eledon Pharmaceuticals: 3 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant RecipientsNCT06126380 | AT-1501, Tacrolimus | Enrolling by invitation | 2029-12Estimated |
| Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770 | AT-1501, Tacrolimus | Completed | 2025-09-11Actual |
| Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)NCT05125068 | AT-1501 | Terminated | 2023-07-31Actual |
Names as written in the registry records.